These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3543069)

  • 21. Short-term efficacy and safety of fenfluramine in hospitalized preschool-age autistic children: an open study.
    Campbell M; Deutsch SI; Perry R; Wolsky BB; Palij M
    Psychopharmacol Bull; 1986; 22(1):141-7. PubMed ID: 3726060
    [No Abstract]   [Full Text] [Related]  

  • 22. [Opiate hypothesis in infantile autism? Therapeutic trials with naltrexone].
    Leboyer M; Bouvard MP; Launay JM; Recasens C; Plumet MH; Waller-Perotte D; Tabuteau F; Bondoux D; Dugas M
    Encephale; 1993; 19(2):95-102. PubMed ID: 8275903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
    Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fenfluramine treatment of twenty children with autism.
    Ekman G; Miranda-Linné F; Gillberg C; Garle M; Wetterberg L
    J Autism Dev Disord; 1989 Dec; 19(4):511-32. PubMed ID: 2606882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fenfluramine treatment in infantile autism. Neurochemical, electrophysiological, and behavioral effects.
    August GJ; Raz N; Papanicolaou AC; Baird TD; Hirsh SL; Hsu LL
    J Nerv Ment Dis; 1984 Oct; 172(10):604-12. PubMed ID: 6384430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fenfluramine and methylphenidate in children with mental retardation and borderline IQ: clinical effects.
    Aman MG; Kern RA; Osborne P; Tumuluru R; Rojahn J; del Medico V
    Am J Ment Retard; 1997 Mar; 101(5):521-34. PubMed ID: 9083608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of bulimia with fenfluramine and desipramine.
    Blouin AG; Blouin JH; Perez EL; Bushnik T; Zuro C; Mulder E
    J Clin Psychopharmacol; 1988 Aug; 8(4):261-9. PubMed ID: 3062043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized controlled trial of transdermal secretin on behavior of children with autism.
    Ratliff-Schaub K; Carey T; Reeves GD; Rogers MA
    Autism; 2005 Jul; 9(3):256-65. PubMed ID: 15937041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tianeptine: a novel strategy of psychopharmacological treatment of children with autistic disorder.
    Niederhofer H; Staffen W; Mair A
    Hum Psychopharmacol; 2003 Jul; 18(5):389-93. PubMed ID: 12858327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preliminary observations on the effect of fenfluramine on blood serotonin and symptoms in three autistic boys.
    Geller E; Ritvo ER; Freeman BJ; Yuwiler A
    N Engl J Med; 1982 Jul; 307(3):165-9. PubMed ID: 7088052
    [No Abstract]   [Full Text] [Related]  

  • 31. A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination.
    Weintraub M; Hasday JD; Mushlin AI; Lockwood DH
    Arch Intern Med; 1984 Jun; 144(6):1143-8. PubMed ID: 6375610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of fenfluramine (hydrochloride) on the behaviors of fifteen autistic children.
    Sherman J; Factor DC; Swinson R; Darjes RW
    J Autism Dev Disord; 1989 Dec; 19(4):533-43. PubMed ID: 2606883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of fenfluramine on behavioral, cognitive, and affective disturbances in autistic children.
    August GJ; Raz N; Baird TD
    J Autism Dev Disord; 1985 Mar; 15(1):97-107. PubMed ID: 3884585
    [No Abstract]   [Full Text] [Related]  

  • 34. Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone.
    McDougle CJ; Scahill L; McCracken JT; Aman MG; Tierney E; Arnold LE; Freeman BJ; Martin A; McGough JJ; Cronin P; Posey DJ; Riddle MA; Ritz L; Swiezy NB; Vitiello B; Volkmar FR; Votolato NA; Walson P
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):201-24. PubMed ID: 10674197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical effects of fenfluramine on children with autism: a review of the research.
    du Verglas G; Banks SR; Guyer KE
    J Autism Dev Disord; 1988 Jun; 18(2):297-308. PubMed ID: 3045076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and neurochemical effects of fenfluramine in children with autism.
    Leventhal BL; Cook EH; Morford M; Ravitz AJ; Heller W; Freedman DX
    J Neuropsychiatry Clin Neurosci; 1993; 5(3):307-15. PubMed ID: 8369641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guanfacine in children with autism and/or intellectual disabilities.
    Handen BL; Sahl R; Hardan AY
    J Dev Behav Pediatr; 2008 Aug; 29(4):303-8. PubMed ID: 18552703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism.
    Coniglio SJ; Lewis JD; Lang C; Burns TG; Subhani-Siddique R; Weintraub A; Schub H; Holden EW
    J Pediatr; 2001 May; 138(5):649-55. PubMed ID: 11343038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary dopamine metabolites as indicators of the responsiveness to fenfluramine treatment in children with autistic behavior.
    Barthelemy C; Bruneau N; Jouve J; Martineau J; Muh JP; Lelord G
    J Autism Dev Disord; 1989 Jun; 19(2):241-54. PubMed ID: 2745390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of atypical antipsychotics in the treatment of autistic disorder.
    Stachnik JM; Nunn-Thompson C
    Ann Pharmacother; 2007 Apr; 41(4):626-34. PubMed ID: 17389666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.